Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells
Open Access
- 30 October 2014
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 45 (2), 428-439
- https://doi.org/10.1183/09031936.00102014
Abstract
Virus-associated pulmonary exacerbations, often associated with rhinoviruses (RVs), contribute to cystic fibrosis (CF) morbidity. Currently, there are only a few therapeutic options to treat virus-induced CF pulmonary exacerbations. The macrolide antibiotic azithromycin has antiviral properties in human bronchial epithelial cells. We investigated the potential of azithromycin to induce antiviral mechanisms in CF bronchial epithelial cells.Primary bronchial epithelial cells from CF and control children were infected with RV after azithromycin pre-treatment. Viral RNA, interferon (IFN), IFN-stimulated gene and pattern recognition receptor expression were measured by real-time quantitative PCR. Live virus shedding was assessed by assaying the 50% tissue culture infective dose. Pro-inflammatory cytokine and IFN-β production were evaluated by ELISA. Cell death was investigated by flow cytometry.RV replication was increased in CF compared with control cells. Azithromycin reduced RV replication seven-fold in CF cells without inducing cell death. Furthermore, azithromycin increased RV-induced pattern recognition receptor, IFN and IFN-stimulated gene mRNA levels. While stimulating antiviral responses, azithromycin did not prevent virus-induced pro-inflammatory responses.Azithromycin pre-treatment reduces RV replication in CF bronchial epithelial cells, possibly through the amplification of the antiviral response mediated by the IFN pathway. Clinical studies are needed to elucidate the potential of azithromycin in the management and prevention of RV-induced CF pulmonary exacerbations.This publication has 43 references indexed in Scilit:
- Influenza A(H1N1)pdm09 and Cystic Fibrosis Lung Disease: A Systematic Meta-AnalysisPLOS ONE, 2014
- Incidence and clinical impact of respiratory viruses in adults with cystic fibrosisThorax, 2013
- Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosisJournal of Cystic Fibrosis, 2012
- Rhinovirus C and Respiratory Exacerbations in Children with Cystic FibrosisEmerging Infectious Diseases, 2010
- Cystic Fibrosis Pulmonary GuidelinesAmerican Journal of Respiratory and Critical Care Medicine, 2009
- The role of respiratory viruses in cystic fibrosisJournal of Cystic Fibrosis, 2008
- Prophylaxis against respiratory syncytial virus in young children with cystic fibrosisPediatric Pulmonology, 2007
- Effect of clarithromycin on rhinovirus-16 infection in A549 cellsEuropean Respiratory Journal, 2006
- Erythromycin Inhibits Rhinovirus Infection in Cultured Human Tracheal Epithelial CellsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Bafilomycin A1inhibits rhinovirus infection in human airway epithelium: effects on endosome and ICAM-1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2001